TCMD

Over the past six months, Tactile Systems Technology, Inc. (TCMD) stock experienced several notable events. On August 10, 2026, the stock plunged 17.12% after the company reported Q2 2026 financial results, despite beating EPS estimates, due to a 7% year-over-year decrease in AffloVest revenue from inventory adjustments by durable medical equipment (DME) partners, with management expecting this pressure to continue through Q3 before normalizing in Q4. On August 20, 2026, an insider (director William W Burke) proposed to sell 15,000 shares of common stock. On July 13, 2026, Tactile Medical announced an exclusive U.S. distribution agreement with ElastiMed for its MyoSleeve wearable compression device for VA and DoD patients. On June 2, 2026, the company launched its next-generation AffloVest airway clearance therapy system. The stock price saw a 7.22% increase on May 4, 2026, and an 17.83% increase on February 17, 2026. In the past three months, insider selling amounted to $323,192.00, with no insider buying. As of August 28, 2026, the stock decreased by 17.78% in the past month and by 7.56% over the past six months.